Cerus (CERS) EBT Growth (1y) (2011 - 2026)
Cerus (CERS) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 5.78% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 74.66% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -27.02% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 103.34% |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 79.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.63% |
| Dec 31, 2025 | 15.75% |
| Sep 30, 2025 | 102.27% |
| Jun 30, 2025 | 3.29% |
| Mar 31, 2025 | 20.51% |
| Dec 31, 2024 | -86.10% |
| Sep 30, 2024 | 60.35% |
| Jun 30, 2024 | 55.94% |
| Mar 31, 2024 | 38.22% |
| Dec 31, 2023 | 90.67% |
| Sep 30, 2023 | 14.74% |
| Jun 30, 2023 | -59.11% |
| Mar 31, 2023 | -27.49% |
| Dec 31, 2022 | -55.99% |
| Sep 30, 2022 | 31.62% |
| Jun 30, 2022 | 45.58% |
| Mar 31, 2022 | 29.67% |
| Dec 31, 2021 | 43.30% |
| Sep 30, 2021 | 12.13% |
| Jun 30, 2021 | -3.24% |